These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15254439)

  • 21. Management of the Hepatitis B Virus/HIV-Coinfected Patient.
    Sherman KE
    Top Antivir Med; 2015; 23(3):111-4. PubMed ID: 26518394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Liver transplantation in patients with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus].
    Duclos-Vallée JC; Roche B; Samuel D
    Presse Med; 2009 Sep; 38(9):1281-9. PubMed ID: 19574023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
    Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B
    Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hepatitis C in HIV-coinfected patients.
    Hughes CA; Shafran SD
    Ann Pharmacother; 2006 Mar; 40(3):479-89; quiz 582-3. PubMed ID: 16507622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.
    Benhamou Y; Bochet M; Thibault V; Calvez V; Fievet MH; Vig P; Gibbs CS; Brosgart C; Fry J; Namini H; Katlama C; Poynard T
    Lancet; 2001 Sep; 358(9283):718-23. PubMed ID: 11551579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
    Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
    J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.
    Dore GJ; Cooper DA; Barrett C; Goh LE; Thakrar B; Atkins M
    J Infect Dis; 1999 Sep; 180(3):607-13. PubMed ID: 10438346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of chronic hepatitis B and C in HIV-coinfected patients.
    Soriano V; Barreiro P; Nuñez M
    J Antimicrob Chemother; 2006 May; 57(5):815-8. PubMed ID: 16556638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of hepatitis B in special patient populations.
    Wang HS; Han SH
    Clin Liver Dis; 2010 Aug; 14(3):505-20. PubMed ID: 20638028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing hepatitis B coinfection in HIV-infected patients.
    Peters MG
    Curr HIV/AIDS Rep; 2005 Aug; 2(3):122-6. PubMed ID: 16091258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.
    Drake A; Mijch A; Sasadeusz J
    Clin Infect Dis; 2004 Jul; 39(1):129-32. PubMed ID: 15206064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of lamivudine (3TC) in the clearance of chronic hepatitis B virus infection in a patient coinfected with human immunodeficiency virus type.
    Schnittman SM; Pierce PF
    Clin Infect Dis; 1996 Sep; 23(3):638-9. PubMed ID: 8879794
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
    Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
    J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
    Bräu N
    J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapy in patients with hepatitis and HIV: weighing risks and benefits.
    Powderly WG
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S109-13. PubMed ID: 14986283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on viral hepatitis in 2004.
    Fung SK; Lok AS
    Curr Opin Gastroenterol; 2005 May; 21(3):300-7. PubMed ID: 15818150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
    Chung RT; Kim AY; Polsky B
    Antivir Chem Chemother; 2001; 12 Suppl 1():73-91. PubMed ID: 11594692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.